$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Osmotic drug delivery system 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
출원번호 US-0359447 (1982-03-18)
발명자 / 주소
  • Higuchi Takeru (Lawrence KS)
출원인 / 주소
  • Merck & Co., Inc. (Rahway NJ 02)
인용정보 피인용 횟수 : 253  인용 특허 : 9

초록

An osmotic drug (or other beneficial substance) delivery system comprises a multi-chamber compartment formed by an external shell and one or more chamber-dividing walls each with a small orifice, of a microporous material and overlayers of semipermeable membranes completely covering the outer shell

대표청구항

An osmotic delivery system shaped and sized for oral ingestion, implantation, rectal, vaginal or ocular insertion, for delivery of a drug or other beneficial substance comprising a compartment consisting of 2 or more chambers in series, the chambers being adapted to house osmotically active agents,

이 특허에 인용된 특허 (9)

  1. Krogseng Gerald P. (Oakdale MN) Paul ; Jr. Fred R. (Burnsville MN), Ballistic inoculation of animals and projectile therefor.
  2. Hudgin Donald Edward (Princeton Junction NJ) Blair Edgar Allan (Cranbury NJ), Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles.
  3. Theeuwes Felix (Los Altos CA) Ayer Atul D. (Belmont CA), Laminated osmotic system for dispensing beneficial agent.
  4. Zaffaroni Alejandro (Atherton CA), Microporous drug delivery device.
  5. Higuchi Takeru (Lawrence KS), Osmotic device with compartment for governing concentration of agent dispensed from device.
  6. Zaffaroni ; Alejandro ; Michaels ; Alan S. ; Theeuwes ; Felix, Osmotic releasing device having a plurality of release rate patterns.
  7. Theeuwes Felix (Los Altos CA), Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina.
  8. Theeuwes Felix (Los Altos CA) Cortese Richard (San Jose CA), System for delivering agent at zero order rate with emerging agent below saturation.
  9. Theeuwes Felix (Los Altos CA), System with microporous releasing diffusor.

이 특허를 인용한 특허 (253)

  1. Beckmann, Christoph Hendrik; Moss, Steven James; Sheridan, Rose Mary; Zhang, Mingqiang; Wilkinson, Barrie, 39-desmethoxy derivatives of rapamycin.
  2. Beckmann, Christoph Hendrik; Moss, Steven James; Sheridan, Rose Mary; Zhang, Mingqiang; Wilkinson, Barrie, 39-desmethoxy derivatives of rapamycin.
  3. Arne, Lawrence; Au-Yeung, Kit Yee; Crandall, Kenneth C.; Robertson, Timothy, Active signal processing personal health signal receivers.
  4. Arne, Lawrence; Au-Yeung, Kit Yee; Crandall, Kenneth C.; Robertson, Timothy, Active signal processing personal health signal receivers.
  5. Arne, Lawrence; Au-Yeung, KitYee; Crandall, Kenneth C.; Robertson, Timothy, Active signal processing personal health signal receivers.
  6. Zhang, Sheng; Ruiz, Rafael, Adhesive compositions for medical use: single additive as both the thickening agent and the accelerator.
  7. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Los Altos CA), Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container.
  8. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Anti-PD-L1 antibodies and uses therefor.
  9. Ford John ; Pace Ann, Anti-interleukin-1 receptor antagonist antibodies and uses thereof.
  10. Sahin, Ugur; Türeci, Özlem; Mitnacht-Kraus, Rita; Wöll, Stefan, Antibodies against Claudin 18.2 useful in cancer diagnosis.
  11. Schebye, Xiao Min; Selby, Mark J.; Han, Michelle Minhua; Bee, Christine; Deng, Andy X.; Chuntharapai, Anan; Devaux, Brigitte; Li, Huiming; Sheppard, Paul O.; Korman, Alan J.; Ardourel, Daniel F.; Deyanova, Ekaterina; Huang, Richard; Chen, Guodong; Kuhne, Michelle; Troung, Hong-An, Antibodies against TIM3 and uses thereof.
  12. Schebye, Xiao Min; Selby, Mark J.; Han, Michelle Minhua; Bee, Christine; Deng, Andy X.; Chuntharapai, Anan; Devaux, Brigitte; Li, Huiming; Sheppard, Paul O.; Korman, Alan J.; Ardourel, Daniel F.; Deyanova, Ekaterina; Huang, Richard; Chen, Guodong; Kuhne, Michelle; Troung, Hong-An, Antibodies against TIM3 and uses thereof.
  13. Sahin, Ugur; Tureci, Ozlem; Mitnacht-Kraus, Rita; Woll, Stefan, Antibodies against claudin 18.2 useful in cancer diagnosis.
  14. Xiao, Shouhua; Pan, Zheng; Wickramasinghe, Dineli; Kufer, Peter; Hoffmann, Patrick; Raum, Tobias; Lutterbüse, Ralf; Nahrwold, Elisabeth; Blumel, Claudia, Antibody constructs for CDH19 and CD3.
  15. Tureci, Ozlem; Sahin, Ugur; Koslowski, Michael; Fritz, Stephan; Geppert, Harald-Gerhard, Antibody to genetic products differentially expressed in tumors and the use thereof.
  16. Bialer Meir,ILX ; Dagan Arie,ILX ; Sherbel Sussan,ILX, Anticonvulsant drugs and pharmaceutical compositions thereof.
  17. Robertson, Timothy; Moon, Gregory; Ionescu, Arna; Behzadi, Yashar; O'Reilly, David; Filner, Aaron; Karplus, Erika; Cojuangco, Danielle; Burgess, Sara, Apparatus, system, and method for managing adherence to a regimen.
  18. Jani, Nilay; Webb, Douglas; Withrington, Jonathan; Berkman, Jeffrey; Li, Haifeng, Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device.
  19. Naidu, Kamatham A., Ascorbyl esters for the treatment of cancer.
  20. Tan, Jun; Town, Terrence; Mullan, Michael, Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology.
  21. John Ford ; Ann Pace, Assays involving an IL-1 receptor antagonist.
  22. Cardinal John R. (Old Lyme CT) Herbig Scott M. (Bend OR) Korsmeyer Richard W. (East Lyme CT) Lo Jeelin (Old Lyme CT) Smith Kelly L. (Bend OR) Thombre Avinash G. (Gales Ferry CT), Asymmetric membranes in delivery devices.
  23. Chen Guohua ; Lautenbach Scott ; Dionne Keith ; Hom Lawton, Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents.
  24. Shults Mark G. (Madison WI) Capelli Christopher C. (Kenosha WI) Updike Stuart J. (Madison WI), Biological fluid measuring device.
  25. Katti, Kattesh V.; Gali, Hariprasad; Volkert, Wynn A., Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents.
  26. Tacey X. Viegas ; Lorraine E. Reeve ; Raymond L. Henry, Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels.
  27. Cojocaru, Gady S.; Rotman, Galit; Levine, Zurit; Dassa, Liat; Levi, Ofer; Briante, Raffaella; Singh, Shweta; Watson, Susan R.; Pergam, Tania, C10RF32 antibodies, and uses thereof for treatment of cancer.
  28. Anderson David W. ; Buuck Robert E. ; Thornton Arnold W. ; Zhang Xiao Kang, Channeled vaginal insert and method for treating urogenital disorders.
  29. St-Arnaud, Rene, Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof.
  30. St-Arnaud, Rene, Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof.
  31. St-Arnaud, Rene, Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof.
  32. St-Arnaud, Rene, Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof.
  33. Smith, Thomas J., Coated particles for sustained-release pharmaceutical administration.
  34. Kemp John D., Combined treatment of iron depletion and IgG antibody.
  35. Hafezi, Hooman; O'Reilly, David; Johnson, Patricia; Hatamkhany, Zahedeh; Robertson, Timothy; Zdeblick, Mark, Communication system incorporated in a container.
  36. Hafezi, Hooman; O'Reilly, David; Johnson, Patricia; Hatamkhany, Zahedeh; Robertson, Timothy, Communication system incorporated in an ingestible product.
  37. Hafezi, Hooman; O'Reilly, David; Johnson, Patricia; Hatamkhany, Zahedeh; Robertson, Timothy, Communication system incorporated in an ingestible product.
  38. Frank, Jeremy; Bjeletich, Peter; Hafezi, Hooman; Azevedo, Robert; Duck, Robert; Pesic, Iliya; Costello, Benedict; Snyder, Eric, Communication system with enhanced partial power source and method of manufacturing same.
  39. Zdeblick, Mark; Robertson, Timothy; Pikelny, Aleksandr; Hafezi, Hooman, Communication system with partial power source.
  40. Zdeblick, Mark; Robertson, Timothy; Pikelny, Aleksandr; Hafezi, Hooman, Communication system with partial power source.
  41. Berkman, Jeffrey; Zdeblick, Mark; Johnson, Patricia; Hafezi, Hooman; Withrington, Jonathan, Communication system with remote activation.
  42. Berkman, Jeffrey; Zdeblick, Mark; Johnson, Patricia; Hafezi, Hooman; Withrington, Jonathan, Communication system with remote activation.
  43. Reyes, Joe, Composition to boost libido.
  44. Leung, Karling Alice, Compositions, devices and methods of use thereof for the treatment of cancers.
  45. Anderson David W. ; Buuck Robert E. ; Thornton Arnold W. ; Zhang Xiao Kang, Compressible vaginal insert and method for treating urogenital disorders.
  46. Bhatt, Ramesh; Horowitz, Lawrence; Xu, Li, Constructs and libraries comprising antibody surrogate light chain sequences.
  47. Thompson, Andrew, Container with electronically controlled interlock.
  48. Hafezi, Hooman; Robertson, Timothy; Colliou, Olivier; Zdeblick, Mark, Controlled activation ingestible identifier.
  49. Hafezi, Hooman; Robertson, Timothy; Colliou, Olivier; Zdeblick, Mark, Controlled activation ingestible identifier.
  50. Chen Chih-Ming ; Xie Jianbo ; Jan Steve, Controlled release bupropion formulation.
  51. Crison, John R.; Amidon, Gordon L., Controlled release of drugs.
  52. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  53. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  54. Li, Boyong; Nangia, Avinash; Chen, Chih Ming; Cheng, Xiu Xiu, Controlled release oral dosage form.
  55. Zhang, Sheng; Azevedo, Max; Ruiz, Sr., Rafael, Curing accelerator and method of making.
  56. Zhang, Sheng; Ruiz, Sr., Rafael; Azevedo, Max, Curing accelerator and method of making.
  57. Lee, Jeoung Soo; Webb, Charles Kenneth; Zimmerman, Robert; Ruiz, Sr., Rafael, Cyanoacrylate tissue adhesives.
  58. Lee, Jeoung Soo; Webb, Charles Kenneth; Zimmerman, Robert; Ruiz, Sr., Rafael; Zhang, Sheng, Cyanoacrylate tissue adhesives.
  59. Zhang, Sheng; Ruiz, Sr., Rafael; Azevedo, Max, Cyanoacrylate tissue adhesives with desirable permeability and tensile strength.
  60. Zhang, Sheng; Ruiz, Rafael, Cyanoacrylate-based liquid microbial sealant drape.
  61. DuBois Mark (Mt. View CA) Theeuwes Felix (Los Altos CA) Wong Patrick S. L. (Hayward CA), Device for administering calcium ascorbate.
  62. DePrince Randolph B. (Terre Haute IN) Viswanathan Ravi (Terre Haute IN), Device for the extended delivery of diffusible agents.
  63. Alessi, Thomas R.; Leung, Karling Alice; Mercer, Ryan D.; Negulescu, Cristina G.; Rohloff, Catherine M.; Yang, Bing, Devices, formulations, and methods for delivery of multiple beneficial agents.
  64. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Dispenser comprising inner and outer walls functioning as cooperative unit.
  65. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Dispenser comprising inner positioned soft or hard capsule.
  66. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Dispenser comprising telescopically engaging members.
  67. Curatolo William J. (Groton CT), Dispensing devices powered by lyotropic liquid crystals.
  68. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug.
  69. Maget Henri J. R. (Los Altos CA) Krejci Paul (Pacific Beach CA), Electrochemically-driven pulsatile drug dispenser.
  70. Shirvani, Alireza; Zdeblick, Mark; Withrington, Jonathan, Electromagnetic sensing and detection of ingestible event markers.
  71. Doud, Darren; Campbell, Randolph E.; Erickson, Signe; MacFarlane, K. Angela; Barrett, Mike; Skieller, Christina; Batten, David; Stine, Greg; de Juan, Jr., Eugene; Sutton, Douglas; Farinas, Kathleen Cogan, Fluid exchange apparatus and methods.
  72. Charles, Matthew, Formulations of human tissue kallikrein-1 for parenteral delivery and related methods.
  73. Tsibris John C. M. ; Porter Kathy B., Guinea pig model for leiomyomas.
  74. Hafezi, Hooman; Au-Yeung, Kityee; Duck, Robert; Holen, Maria Casillas; Robertson, Timothy; Costello, Benedict James, Highly reliable ingestible event markers and methods for using the same.
  75. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Human anti-PD-1 antibodies and uses therefor.
  76. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor.
  77. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark, Human tissue kallikrein 1 glycosylation isoforms.
  78. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark, Human tissue kallikrein 1 glycosylation isoforms.
  79. Silverstrini Thomas A., Hybrid intrastromal corneal ring.
  80. Silverstrini Thomas A., Hybrid intrastromal corneal ring.
  81. Silverstrini, Thomas A., Hybrid intrastromal corneal ring.
  82. Silvestrini Thomas A., Hybrid intrastromal corneal ring.
  83. Katti Kattesh V. ; Singh Prahlad R. ; Reddy V. Sreenivasa ; Katti Kavita K. ; Volkert Wynn A. ; Ketring Alan R., Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals.
  84. Katti Kattesh V. ; Karra Srinivasa Rao ; Berning Douglas E. ; Smith C. Jeffrey ; Volkert Wynn A. ; Ketring Alan R., Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same.
  85. Katti Kattesh V. ; Karra Srinivasa Rao ; Berning Douglas E. ; Smith C. Jeffrey ; Volkert Wynn A. ; Ketring Alan R., Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same.
  86. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Usener, Dirk, Identification of tumor-associated antigens for diagnosis and therapy.
  87. Sahin, Ugur; Türeci, Özlem; Koslowski, Michael; Usener, Dirk, Identification of tumor-associated antigens for diagnosis and therapy.
  88. Hadden, John W., Immunotherapy for reversing immune suppression.
  89. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  90. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  91. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  92. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  93. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  94. Colliou, Olivier; Robertson, Timothy; Zdeblick, Mark, In-body device having a multi-directional transmitter.
  95. Robertson, Timothy; Zdeblick, Mark, In-body device having deployable antenna.
  96. Hafezi, Hooman; Costello, Benedict James; Robertson, Timothy L.; Casillas Holen, Maria, In-body device with virtual dipole signal amplification.
  97. Hafezi, Hooman; Costello, Benedict; Robertson, Timothy; Holen, Maria Casillas, In-body device with virtual dipole signal amplification.
  98. Hafezi, Hooman; Robertson, Timothy; Snyder, Eric; Cozad, Brad, In-body power source having high surface area electrode.
  99. Hafezi, Hooman; Snyder, Eric J.; Costello, Benedict, Ingestible circuitry.
  100. Hafezi, Hooman; Snyder, Eric J.; Costello, Benedict, Ingestible circuitry.
  101. Hafezi, Hooman; Schmidt, Raymond, Ingestible device with pharmaceutical product.
  102. Duck, Robert; Savage, George; Johnson, Patricia; Zdeblick, Mark; Costello, Benedict; Au-Yeung, Kityee; Robertson, Timothy; Hafezi, Hooman, Ingestible event markers comprising an ingestible component.
  103. Jensen, Marc; Leichner, Robert; Beaulieu, Patrick; Au-Yeung, Kit Yee; Arne, Lawrence; Zdeblick, Mark; Thompson, Andrew; Savage, George; Robertson, Timothy; Behzadi, Yashar, Ingestion-related biofeedback and personalized medical therapy method and system.
  104. Helliwell, James A.; Malone, Amanda M.; Smith, Thomas J.; Baum, Marc M., Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith.
  105. Chou, Kang-Jye; Guo, Hong; Ashton, Paul; Shimizu, Robert W.; Watson, David A., Injectable sustained release delivery devices.
  106. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Doud, Darren; Erickson, Signe; Barrett, Mike; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  107. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Doud, Darren; Erickson, Signe; Barrett, Mike; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  108. de Juan, Jr., Eugene; Erickson, Signe; Campbell, Randolph E.; Doud, Darren; Barrett, Michael; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  109. de Juan, Jr., Eugene; Campbell, Randolph E.; Erickson, Signe; Barrett, Mike; Skieller, Christina; Batten, David; Doud, Darren, Insertion and removal methods and apparatus for therapeutic devices.
  110. Hafezi, Hooman; Duck, Robert; Robertson, Timothy; Costello, Benedict, Integrated ingestible event marker system with pharmaceutical product.
  111. Ford, John; Ho, Alice Suk-Yue; Pace, Ann, Interleukin--1 receptor antagonist and uses thereof.
  112. John Ford ; Ann Pace, Interleukin-1 receptor antagonist and recombinant production thereof.
  113. Platt, Adam Samuel; Rapecki, Stephen Edward; Fortunato, Mara; Rainey, David Robert; Rundle, Jon Leigh; Smith, Paul Alfred; Watt, Gillian Sairfull, Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy.
  114. Zhang, Sheng; Ruiz, Sr., Rafael, Low dose gamma sterilization of liquid adhesives.
  115. Arne, Lawrence; Zdeblick, Mark; Dua, Aditya; Savage, George; Leichner, Robert; Shenasa, Jafar; Johnson, Patricia; Schmidt, Raymond; Hatamkhany, Zahedeh; Muralidharan, Veeraperurnanallu, Masticable ingestible product and communication system therefor.
  116. Eckenhoff James B. (Los Altos CA), Means for providing instant agent from agent dispensing system.
  117. Viegas Tacey X. (Canton MI) Reeve Lorraine E. (Dexter MI) Henry Raymond L. (Grosse Pointe Woods MI), Medical uses of in situ formed gels.
  118. Viegas Tacey X. ; Reeve Lorraine E. ; Henry Raymond L., Medical uses of in situ formed gels.
  119. Viegas Tacey X. ; Reeve Lorraine E. ; Henry Raymond L., Medical uses of in situ formed gels.
  120. Silvia S. Jurisson ; Thomas P. Quinn ; Michael F. Giblin, Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma.
  121. Schmidt, Raymond; Johnson, Patricia; Holen, Maria; Huang, Richard; Thai, Alvin, Metal detector apparatus, system, and method.
  122. Reeve Lorraine E. ; Flore Stephen G., Method and composition for inhibiting post-surgical adhesions.
  123. Vardimon Lily,ILX, Method and composition for treating neuronal degeneration.
  124. Harpal S. Mangat ; Gerry Ballough ; Gary Brown, Method and composition for treatment of ischemic neuronal reperfusion injury.
  125. Raymond L. Henry ; Lorraine E. Reeve ; Stephen G. Flore ; Frederick J. Foley, Method and non-gelling composition for inhibiting post-surgical adhesions.
  126. Zha, Dongxing, Method for preparing Fc containing polypeptides having improved properties.
  127. Benayahu Dafna (Herzlia ILX) Wientroub Shlomo (Tel-Aviv ILX), Method for regulating bone forming cells.
  128. Zuckerman,Kenneth S.; Liu,Richard Y., Method for the inhibition of function of STAT transcription factors.
  129. Zuckerman, Kenneth S.; Liu, Richard Y., Method for the modulation of function of transcription factors.
  130. Zuckerman,Kenneth S.; Liu,Richard Y., Method for the modulation of function of transcription factors.
  131. Ashton, Paul, Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
  132. Shyam S. Mohapatra ; Hiroto Matsuse ; Aruna K. Behera ; Mukesh Kumar, Method of intranasal gene transfer for protection against respiratory infection.
  133. Viegas Tacey X. (Canton MI) Reeve Lorraine E. (Dexter MI) Henry Raymond L. (St. Clair Shores MI), Method of making thermoreversible polyoxyalkylene gels.
  134. Zhang, Sheng; Ruiz, Rafael, Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator.
  135. Levy, Efrat, Methods and compositions relating to cystatin C.
  136. De Colle, Cyril; Pasricha, Pankaj, Methods for treating GI tract disorders.
  137. De Colle, Cyril; Pasricha, Pankaj, Methods for treating GI tract disorders.
  138. Eliaz, Rom Ezer; Zhang, Yuanpeng; Rohloff, Catherine Manya; Weeks, Eric William; Junnarkar, Gunjan, Methods of manufacturing viscous liquid pharmaceutical formulations.
  139. Pellman, David, Methods of treating a meiotic kinesin associated disease.
  140. Pellman, David, Methods of treating a meiotic kinesin associated disease.
  141. Pellman, David, Methods of treating a meiotic kinesin-associated disease.
  142. Maloney, Kevin, Methods of treating inflammatory disorders using high concentration natalizumab compositions.
  143. Robertson, Timothy; Hafezi, Hooman; Schmidt, Raymond, Miniature ingestible device.
  144. Robertson, Timothy; Hafezi, Hooman; Schmidt, Raymond, Miniature ingestible device.
  145. Zdeblick, Mark; Stoll, Arna Ionescu; McAllister, William; Au-Yeung, Kit Yee, Mobile device and system for detection and communication of information received from an ingestible device.
  146. Paris, Daniel; Town, Terrence C.; Mullan, Michael J., Modulation of the phospholipase A2 pathway as a therapeutic.
  147. Sahin, Ugur; Tureci, Ozlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schroder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  148. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  149. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  150. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  151. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  152. Sahin, Ugar; Koslowski, Michael; Tureci, Ozlem, Monoclonal antibodies for treatment of cancer.
  153. Sahin, Ugur; Koslowski, Michael; Tureci, Ozlem, Monoclonal antibodies for treatment of cancer.
  154. Sahin, Ugur; Koslowski, Michael; Türeci, Özlem, Monoclonal antibodies for treatment of cancer.
  155. Sahin, Ugur; Koslowski, Michael; Türeci, Özlem, Monoclonal antibodies for treatment of cancer.
  156. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnacht-Kraus, Rita, Monoclonal antibodies for treatment of cancer.
  157. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnachtkraus, Rita, Monoclonal antibodies for treatment of cancer.
  158. Robertson, Timothy; Zdeblick, Mark, Multi-mode communication ingestible event markers and systems, and methods of using the same.
  159. Robertson, Timothy; Zdeblick, Mark, Multi-mode communication ingestible event markers and systems, and methods of using the same.
  160. Jarvis, Gary A.; John, Constance M.; Leffler, Hakon, N-terminally truncated galectin-3 for use in treating cancer.
  161. Horowitz, Lawrence; Bhatt, Ramesh; Kashyap, Arun, Neutralizing molecules to influenza viruses.
  162. Chopp, Michael; Zhang, Rui Lan, Nitric oxide donors for inducing neurogenesis.
  163. Chopp, Michael; Zhang, Rui Lan, Nitric oxide donors for inducing neurogenesis.
  164. Chopp,Michael; Zhang,Rui Lan, Nitric oxide donors for inducing neurogenesis.
  165. Bianchi, Keith; Hartsig, Bill; Nunn, Scott; Patel, Mukund; Sponsel, Mark; Vedrine, Lionel; Waitz, Ariel, Ocular implant delivery device and method.
  166. Feinstein, Elena; Adamsky, Svetlana; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor, Oligonucleotide modulators of the toll-like receptor pathway.
  167. Feinstein, Elena; Adamsky, Svetlana; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor, Oligonucleotide modulators of the toll-like receptor pathway.
  168. Erickson, Signe; Campbell, Randolph E.; Doud, Darren, Ophthalmic implant for delivering therapeutic substances.
  169. Bettencourt, Brian Richard; Bumcrot, David Anton; Huesken, Dieter; Kuchimanchi, Satyanarayana; Milstein, Stuart; Schlabach, Jr., Michael Ray; Stegmeier, Frank Peter; Warmuth, Markus; Weiler, Jan, Organic compositions to treat beta-catenin-related diseases.
  170. Alessi, Thomas R.; Mercer, Ryan D.; Rohloff, Catherine M.; Yang, Bing, Osmotic delivery device comprising an insulinotropic peptide and uses thereof.
  171. Peterson, Lewis L.; Maruyama, Fred H.; Dehnad, Houdin; Hom, Lawton; Ly, Kevin S.; Davis, Craig R.; Peery, John R., Osmotic delivery system flow modulator apparatus and method.
  172. Peterson, Lewis L.; Maruyama, Fred H.; Dehnad, Houdin; Hom, Lawton; Ly, Kevin S.; Davis, Craig R.; Peery, John R., Osmotic delivery system flow modulator apparatus and method.
  173. Peterson,Lewis L.; Maruyama,Fred H.; Dehnad,Houdin; Hom,Lawton; Ly,Kevin S.; Davis,Craig R.; Peery,John R., Osmotic delivery system flow modulator apparatus and method.
  174. Ayer Rupal, Osmotic delivery system with membrane plug retention mechanism.
  175. Ayer, Rupal, Osmotic delivery system with membrane plug retention mechanism.
  176. Ayer, Rupal, Osmotic delivery system with membrane plug retention mechanism.
  177. Chen Guohua ; Lautenbach Scott D. ; Dionne Keith E. ; Jordan Scott D. ; Berry Steve A. ; Rodenberger Craig I. ; Ayer Rupal, Osmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems.
  178. Chen, Guohua; Lautenbach, Scott D.; Dionne, Keith E.; Jordan, Scott D.; Berry, Steve A.; Rodenberger, Craig I.; Ayer, Rupal, Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems.
  179. Ayer Rupal ; Eckenhoff James B. ; Berry Stephen A. ; Stewart Gregory R. ; Jordan Scott D., Osmotic drug delivery monitoring system and method.
  180. Frostegård, Johan, Oxidized cardiolipin as a pro-inflammatory factor.
  181. Zdeblick, Mark J.; Thompson, Andrew; Savage, George M., Patient customized therapeutic regimens.
  182. Richard Y. Liu ; Kenneth S. Zuckerman, Peptide antagonists of tumor necrosis factor alpha.
  183. Zdeblick, Mark; Pikelny, Aleksandr; Robertson, Timothy; Hafezi, Hooman, Pharma-informatics system.
  184. Zdeblick, Mark; Thompson, Andrew; Pikelny, Aleksandr; Robertson, Timothy; Hafezi, Hooman, Pharma-informatics system.
  185. Zdeblick, Mark; Thompson, Andrew; Pikelny, Aleksandr; Robertson, Timothy; Hafezi, Hooman, Pharma-informatics system.
  186. Baker Richard W. (Mountain View CA) Brooke James W. (Sisters OR), Pharmaceutical delivery system.
  187. Hafezi, Hooman; Moon, Gregory; Au-Yeung, Kityee; Duck, Robert; Holen, Maria Casillas, Pharmaceutical dosages delivery system.
  188. Gygi, Steven P.; Villen, Judit; Beausoleil, Sean, Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides.
  189. Cohen-Dayag, Anat; Beiman, Merav; Dassa, Liat; Bubis, Marina; Greenwald, Shirley Sameach-; Landesman-Milo, Dalit; Koifman, Cynthia; Levy, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Levine, Zurit; Rosenberg, Avi; Rotman, Galit; Montia, Eve; Novik, Amit; Toporik, Amir; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  190. Levine, Zurit; Pergam, Tania; Landesman-Milo, Dalit; Cohen-Dayag, Anat; Toporik, Amir; Kinar, Yaron; Nemzer, Sergey; Rosenberg, Avi; Rotman, Galit; Novik, Amit; Koifman, Cynthia; Beiman, Merav; Dassa, Liat; Walach, Shira; Montia, Eve; Sameach-Greenwald, Shirley; Levy, Ofer; Bubis, Marina, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  191. Levine, Zurit; Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levy, Ofer; Nemzer, Sergey; Walach, Shira; Greenwald, Shirley Sameach-; Pergam, Tania; Kinar, Yaron, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  192. Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi Yeshah; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levi, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Greenwald, Shirley Sameach-; Levine, Zurit; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  193. Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi Yeshah; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levy, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Sameach-Greenwald, Shirley; Levine, Zurit; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  194. Toporik, Amir; Rosenberg, Avi Yeshah; Rotman, Galit; Hecht, Iris; Levine, Zurit, Polypeptides and uses thereof for treatment of autoimmune disorders and infection.
  195. Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Farinas, Kathleen C., Posterior segment drug delivery.
  196. Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Farinas, Kathleen C., Posterior segment drug delivery.
  197. de Juan, Jr., Eugene; Alster, Yair; Chamow, Steven M.; Farinas, Kathleen Cogan; Giffor, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; George, Robert; Sutton, Douglas, Posterior segment drug delivery.
  198. de Juan, Jr., Eugene; Alster, Yair; Chamow, Steven M.; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; Macfarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; George, Robert; Sutton, Douglas, Posterior segment drug delivery.
  199. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  200. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  201. de Juan, Jr., Eugene; Alster, Yair; Gifford, III, Hanson S.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  202. Robertson, Timothy L.; Behzadi, Yashar, Probablistic pharmacokinetic and pharmacodynamic modeling.
  203. Reeve Lorraine E. ; Hinsberg Michael G., Process for the fractionation of polyoxyalkylene block copolymers.
  204. De Colle, Cyril; Pasricha, Pankaj; Wustrow, David, Prodrugs of metopimazine.
  205. Gregory, Matthew Alan; Martin, Christine Janet, Production of polyketides and other natural products.
  206. Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA) Wong Patrick S. L. (Hayward CA), Pulsed drug delivery.
  207. Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA) Wong Patrick S. L. (Hayward CA), Pulsed drug delivery.
  208. Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA) Wong Patrick S. (Hayward CA), Pulsed drug delivery of doxylamine.
  209. Sattler, Michael; Popowicz, Grzegorz; Dawidowski, Maciej; Emmanouilidis, Leonidas; Erdmann, Ralf; Schliebs, Wolfgang; Kalel, Vishal, Pyrazolopyridine derivatives and their use in therapy.
  210. Sattler, Michael; Popowicz, Grzegorz; Dawidowski, Maciej; Emmanouilidis, Leonidas; Erdmann, Ralf; Schliebs, Wolfgang; Kalel, Vishal, Pyrazolopyridine derivatives and their use in therapy.
  211. Alessi, Thomas R.; Luskey, Kenneth, Rapid establishment and/or termination of substantial steady-state drug delivery.
  212. Whitehead Derek J. (Poynton GB2) Shepherd Michael T. (Cheddington GB2), Release device.
  213. Varner, Signe Erickson; De Juan, Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  214. Varner, Signe Erickson; Dejuan, Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  215. Varner, Signe Erickson; de Juan, Jr., Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  216. De Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Erickson, Signe, Small molecule delivery with implantable therapeutic device.
  217. Thompson, Andrew; Thompson, Todd; Behzadi, Yashar; Abraham, Danielle Cojuangco; Duck, Robert; Ionescu, Arna; Lee, Ray; Suchan, Robin; Turner, William; Muralidharan, Veeraperumanallu; Karplus, Erika; Savage, George, Social media networking based on physiologic information.
  218. Rohloff, Catherine M.; Chen, Guohua; Luk, Andrew S.; Ayer, Rupal A.; Houston, Paul R.; Desjardin, Michael A.; Zamora, Pauline; Lam, Stan, Solvent/polymer solutions as suspension vehicles.
  219. Margolin, Alexey L.; Khalaf, Nazar K.; St. Clair, Nancy L.; Rakestraw, Scott L.; Shenoy, Bhami C., Stabilized protein crystals, formulations comprising them and methods of making them.
  220. Horvath, Judit; Astafieva, Irina; Erickson, Signe; Farinas, Kathleen Cogan, Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof.
  221. Horvath, Judit; Astafieva, Irina; Erickson, Signe; Farinas, Kathleen Cogan, Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof.
  222. Zhang, Sheng; Ruiz, Rafael, Stable and sterile tissue adhesive composition with a controlled high viscosity.
  223. Rehder, Douglas; Bondarenko, Pavel; Chelius, Dirk; McAuley, Arnold; Matsumura, Masazumi, Stable polypeptide formulations.
  224. Rehder, Douglas; Bondarenko, Pavel; Chelius, Dirk; McAuley, Arnold; Matsumura, Masazumi, Stable polypeptide formulations.
  225. Behzadi, Yashar, State characterization based on multi-variate data fusion techniques.
  226. Zhang, Sheng; Ruiz, Sr., Rafael; Phelps, Shannon, Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides.
  227. Zhang, Sheng; Ruiz, Sr., Rafael, Sterilized liquid compositions of cyanoacrylate monomer mixtures.
  228. Zhang, Sheng; Ruiz, Sr., Rafael, Sterilized liquid compositions of cyanoacrylate monomer mixtures.
  229. Kashyap, Arun K.; Bhatt, Ramesh R.; Horowitz, Michael; Horowitz, Lawrence; Zhou, Sihong; O'Neil, Ryann E.; Hannum, Charles H.; Kurtzman, Aaron L.; Xu, Li, Surrogate binding proteins which bind DR4 and/or DR5.
  230. Fujioka Keiji (Ibaraki JPX) Sato Shigeji (Ibaraki JPX) Takada Yoshihiro (Ibaraki JPX) Sasaki Yoshio (Ibaraki JPX) Tamura Nobuhiko (Ibaraki JPX), Sustained pulsewise release pharmaceutical preparation.
  231. Chen Jianbing ; Ashton Paul, Sustained release drug delivery devices.
  232. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  233. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  234. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  235. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  236. Hong Guo ; Paul Ashton, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  237. Scully Marlan O. (Estancia NM), Sustained release medicating device for livestock.
  238. Jao, Frank; Wong, Patrick S. -L.; Huynh, Hoa T.; Mc Chesney, Kathy; Wat, Pamela K., System for delaying drug delivery up to seven hours.
  239. Zdeblick, Mark J., System for supply chain management.
  240. Astafieva, Irina; Horvath, Judit; Farinas, Kathleen Cogan; Bueche, Blaine; Erickson, Signe, Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant.
  241. Costello, Benedict; Robertson, Timothy; Johnson, Patricia; Duck, Robert; Huang, Richard; Nicholas, Rod; Cozad, Brad; Hafezi, Hooman; Scheinpflug, Kurt; Hatamkhany, Zahedeh, Techniques for manufacturing ingestible event markers comprising an ingestible component.
  242. Alessi, Thomas R.; Baron, Michelle, Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c.
  243. Lautenbach, Scott C.; De La Serna, Pedro E.; Zamora, Pauline C.; Desjardin, Michael A., Two-piece, internal-channel osmotic delivery system flow modulator.
  244. Cardinal John R. (Groton CT) Herbig Scott M. (Groton CT) Korsmeyer Richard W. (Groton CT) Lo Jeelin (Groton CT) Smith Kelly L. (Groton CT) Thombre Avinash G. (Groton CT), Use of asymmetric membranes in delivery devices.
  245. Herbig Scott Max ; Korsmeyer Richard Wilker ; Thombre Avinash Govind, Use of interfacially-polymerized membranes in delivery devices.
  246. Joanne E. Murphy-Ullrich ; Solange M. F. Ribeiro ; Christian Hugo DE; David D. Roberts ; Henry C. Krutzsch, Use of peptides inhibitory for thrombospondin dependent TGF-.beta. activation in the treatment of kidney disease.
  247. Hadden, John W.; Signorelli, Kathy; Egan, James, Vaccine immunotherapy.
  248. Hadden, John W., Vaccine immunotherapy for immune suppressed patients.
  249. Hadden,John W., Vaccine immunotherapy for immune suppressed patients.
  250. Anderson David W. ; Buuck Robert E. ; Thornton Arnold W. ; Zhang Xiao Kang, Vaginal insert and method for treating urogenital disorders.
  251. Carr, John P.; Eckenhoff, James B., Valve for osmotic devices.
  252. Carr, John P.; Eckenhoff, James B., Valve for osmotic devices.
  253. Thomas Thomas N. ; Mullan Michael, Vasoactive effects and free radical generation by .beta.-amyloid peptides.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로